Menu Search
Equities

Maravai LifeSciences Holdings Inc

MAR:DUS

Maravai LifeSciences Holdings Inc

Actions
  • Price (EUR)5.00
  • Today's Change-0.40 / -7.41%
  • Shares traded--
  • 1 Year change+7.30%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 15:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Maravai LifeSciences Holdings Inc's revenues fell -67.28% from 883.00m to 288.95m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a gain of 220.21m to a loss of 119.03m.
Gross margin46.36%
Net profit margin-116.68%
Operating margin-73.90%
Return on assets-18.23%
Return on equity-51.98%
Return on investment-23.39%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Maravai LifeSciences Holdings Inc fell by 57.18m. However, the company earned 126.22m from its operations for a Cash Flow Margin of 43.68%. In addition the company used 122.31m on investing activities and also paid 61.09m in financing cash flows.
Cash flow per share-2.04
Price/Cash flow per share--
Book value per share1.37
Tangible book value per share-0.113
More ▼

Balance sheet in USDView more

Maravai LifeSciences Holdings Inc has a Debt to Total Capital ratio of 47.46%, a lower figure than the previous year's 106.22%.
Current ratio10.74
Quick ratio9.94
Total debt/total equity1.60
Total debt/total capital0.4746
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.